Document is current
Any future updates will be listed below
-
Authors
Kamal, Ahmed https://orcid.org/0000-0003-0957-0977
Ghazy, Ramy Mohamed https://orcid.org/0000-0001-7611-706X
Sherief, Dalia https://orcid.org/0000-0003-1046-643X
Ismail, Aliaa https://orcid.org/0000-0001-6693-9502
Ellakany, Walid Ismail https://orcid.org/0000-0003-4421-0205
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05035186 at ClinicalTrials.govDocuments that mention this clinical trial
Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial
https://doi.org/10.1186/s12879-023-07993-8
-
Funding
Funding for this research was provided by:
Alexandria University
- License Information
-
More Information
Article History
Received: 12 July 2022
Accepted: 9 January 2023
First Online: 20 January 2023
Declarations
:
: The study protocol got approval by the Ethical Committee of the Faculty of Medicine, Alexandria University, Egypt (Approval Number: 00012098) and the study was performed following the good clinical practice and the ethical principles for the medical research involving human subjects of the Declaration of Helsinki. Written informed consent was obtained from each participant.
: Not applicable.
: The authors declare that they have no competing interests.
